We use cookies to deliver our online services. Details and instructions on how to disable those cookies are set out at nortonrosefulbright.com/cookies-policy. By continuing to use this website you agree to our use of our cookies unless you have disabled them.

Corporate and commercial disputes review

Welcome to the fourth edition of Corporate and commercial disputes review, in which we examine developments that are likely to affect our corporate clients.

Since the UK’s vote to leave the European Union in June, Brexit has become a key area of interest for companies across all industries. From a disputes perspective, we look at how Brexit could impact upon exclusive jurisdiction clauses, service of process and enforcement of judgments and see why, practically, there is likely to be little material change.

Away from Brexit, we examine several key recent cases, including decisions of the Supreme Court on illegality, retention of title and termination of agency arrangements. We also review two important decisions concerning repudiatory breach and directors’ duties.

In other areas affecting companies, we look at establishing a culture of compliance and the rules governing witness preparation in Germany.

Finally, we consider a recent landmark decision on the recovery of third party funding costs in arbitration and the possible impact for the future of this growing area.

Contact

Recent publications

OFAC published a final rule that modifies the Cuban Assets Control Regulations to revoke the so-called "U-turn" authorization.

Publication | September 2019

Sanctions and export controls

Recommended changes to improve Australia’s Medical Cannabis laws

On 5 September 2019, Professor John McMillan AO’s Final Report (Report) on the operation of the Narcotic Drugs Act 1967 (ND Act) was tabled in Parliament. Section 26A of the ND Act required the Minster to cause a review of the operation of the ND Act to be undertaken.